Literature DB >> 21306211

Reno-cerebrovascular disease: linking the nephron and neuron.

Meng Lee1, Bruce Ovbiagele.   

Abstract

Chronic kidney disease (CKD), a growing public health concern, carries a substantial burden and is a well-known independent predictor of coronary artery disease outcomes. In the last few years, attention has been focused on various CKD indices and their prognostic impact among individuals with, or at risk for, cerebrovascular disease. Mounting evidence suggests that the presence of CKD in various forms (filtration rate and barrier impairments), and even at mild stages, is associated with surrogate cerebrovascular disease markers, confers higher future risk of ischemic and hemorrhagic cerebrovascular events, and predicts poor clinical outcomes after an index stroke. However, a better understanding of these links is required. For instance, the direction and strength of the association of CKD with a heterogeneous vascular disease entity, such as cerebrovascular disease (vs coronary artery disease), appears to be greatly influenced by stroke type and ischemic stroke subtype, as well as CKD index and CKD stage. Furthermore, the potential mechanisms underlying the independent relation of baseline CKD and stroke risk need to be better delineated, since a causal association cannot be assumed. Additional investigation is also warranted to clarify whether CKD indices can usefully enhance cerebrovascular disease stratification beyond traditional risk factors. In the meantime, with several recent systematic reviews of published evidence supporting a robust and independent association of CKD with subsequent cerebrovascular disease risk, optimal implementation of established stroke risk reduction strategies in individuals with CKD might improve stroke outcomes. This article summarizes the compelling epidemiological and clinical evidence relating CKD to stroke, and presents the rationale for conducting future studies to assess the role of CKD as a risk marker or potential therapeutic target in individuals with, or at risk for, stroke.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21306211     DOI: 10.1586/ern.10.204

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  8 in total

Review 1.  Stroke epidemiology: advancing our understanding of disease mechanism and therapy.

Authors:  Bruce Ovbiagele; Mai N Nguyen-Huynh
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

2.  Plasma levels of sirtuin-1 in patients with cerebrovascular stroke.

Authors:  Imam M Esmayel; Samia Hussein; Ehab A Gohar; Huda F Ebian; Mayada M Mousa
Journal:  Neurol Sci       Date:  2021-01-28       Impact factor: 3.307

Review 3.  International epidemiology of intracerebral hemorrhage.

Authors:  M Arfan Ikram; Renske G Wieberdink; Peter J Koudstaal
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

4.  Association of renal biomarkers with 3-month and 1-year outcomes among critically ill acute stroke patients.

Authors:  Ying-Chih Huang; Yi-Ling Wu; Ming-Hsueh Lee; Jiann-Der Lee; Chih-Ying Wu; Huan-Lin Hsu; Ya-Hui Lin; Yen-Chu Huang; Wen-Hung Huang; Hsu-Huei Weng; Jen-Tsung Yang; Meng Lee; Bruce Ovbiagele
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

5.  Patterns of care quality and prognosis among hospitalized ischemic stroke patients with chronic kidney disease.

Authors:  Bruce Ovbiagele; Lee H Schwamm; Eric E Smith; Maria V Grau-Sepulveda; Jeffrey L Saver; Deepak L Bhatt; Adrian F Hernandez; Eric D Peterson; Gregg C Fonarow
Journal:  J Am Heart Assoc       Date:  2014-06-05       Impact factor: 5.501

6.  Renal impairment in stroke patients: A comparison between the haemorrhagic and ischemic variants.

Authors:  Pratyush Shrestha; Shalima Thapa; Shikher Shrestha; Subash Lohani; Suresh Bk; Oscar MacCormac; Lekhjung Thapa; Upendra Prasad Devkota
Journal:  F1000Res       Date:  2017-08-21

Review 7.  Representation and reporting of kidney disease in cerebrovascular disease: A systematic review of randomized controlled trials.

Authors:  Ioannis Konstantinidis; Shanti Patel; Marianne Camargo; Achint Patel; Priti Poojary; Steven G Coca; Girish N Nadkarni
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

Review 8.  Qi Fu Yin-a Ming Dynasty Prescription for the Treatment of Dementia.

Authors:  Wei-Yi Ong; Ya-Jun Wu; Tahira Farooqui; Akhlaq A Farooqui
Journal:  Mol Neurobiol       Date:  2018-02-07       Impact factor: 5.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.